SKI Market

A+| A| A-|

Indian Indices

Sensex

74,563.92 -1,470.50
( -1.93%)

Global Indices

Nasdaq

46,583.62 -115.24
(-0.25%)

Dow Jones

6,653.27 -40.35
(-0.60%)

Hang Seng

53,838.16 -614.80
(-1.13%)

Nikkei 225

10,249.42 -55.73
(-0.54%)

Forex

USD-INR

92.29 0.37
(0.40%)

EUR-INR

106.44 -0.15
(-0.14%)

GBP-INR

123.36 -0.03
(-0.03%)

JPY-INR

0.58 0.00
(0.05%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Cipla Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500087

INE059A01026

411.5552288

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

CIPLA

23.17

106150.46

EPS(TTM)

Face Value()

Div & Yield %

56.72

1.22

Back

Atharv Enterprises standalone net profit declines 20.00% in the September 2025 quarter

Nov 11,2025

Net profit of Atharv Enterprises declined 20.00% to Rs 0.04 crore in the quarter ended September 2025 as against Rs 0.05 crore during the previous quarter ended September 2024. Sales reported to Rs 0.02 crore in the quarter ended September 2025. There were no Sales reported during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	0.02	0	0
OPM %	-2600.00	0	-
PBDT	0.08	0.08	0
PBT	0.05	0.07	-29
NP	0.04	0.05	-20

74,563.92 -1,470.50 ( -1.93%)

46,583.62 -115.24 (-0.25%)

6,653.27 -40.35 (-0.60%)

53,838.16 -614.80 (-1.13%)

10,249.42 -55.73 (-0.54%)

92.29 0.37 (0.40%)

106.44 -0.15 (-0.14%)

123.36 -0.03 (-0.03%)

0.58 0.00 (0.05%)